Literature DB >> 9465099

Negative regulation of granulocytic differentiation in the myeloid precursor cell line 32Dcl3 by ear-2, a mammalian homolog of Drosophila seven-up, and a chimeric leukemogenic gene, AML1/ETO.

M Y Ahn1, G Huang, S C Bae, H J Wee, W Y Kim, Y Ito.   

Abstract

The polyomavirus enhancer binding protein 2alphaB (AML1/PEBP2alphaB/Cbfa2) plays a pivotal role in granulocyte colony-stimulating factor (G-CSF)-mediated differentiation of a myeloid progenitor cell line, 32Dc13. In this article, we report the identification of a PEBP2alphaB interacting protein, Ear-2, an orphan member of the nuclear hormone receptor superfamily that directly binds to and can inhibit the function of PEBP2alphaB. Ear-2 is expressed in proliferating 32Dc13 cells in presence of interleukin 3 but is down-regulated during differentiation induced by G-CSF. Interestingly, AML1/ETO(MTG8), a leukemogenic chimeric protein can block the differentiation of 32Dc13 cells, which is accompanied by the sustained expression of ear-2. Overexpression of Ear-2 can prevent G-CSF-induced differentiation, strongly suggesting that ear-2 is a key negative regulator of granulocytic differentiation. Our results indicate that a dynamic balance existing between PEBP2alphaB and Ear-2 appears to determine the choice between growth or differentiation for myeloid cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9465099      PMCID: PMC19195          DOI: 10.1073/pnas.95.4.1812

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt.

Authors:  P Erickson; J Gao; K S Chang; T Look; E Whisenant; S Raimondi; R Lasher; J Trujillo; J Rowley; H Drabkin
Journal:  Blood       Date:  1992-10-01       Impact factor: 22.113

2.  The Drosophila seven-up gene, a member of the steroid receptor gene superfamily, controls photoreceptor cell fates.

Authors:  M Mlodzik; Y Hiromi; U Weber; C S Goodman; G M Rubin
Journal:  Cell       Date:  1990-01-26       Impact factor: 41.582

3.  Identification of a region which directs the monocytic activity of the colony-stimulating factor 1 (macrophage colony-stimulating factor) receptor promoter and binds PEBP2/CBF (AML1).

Authors:  D E Zhang; K Fujioka; C J Hetherington; L H Shapiro; H M Chen; A T Look; D G Tenen
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

4.  Transcriptional regulation of human apolipoprotein genes ApoB, ApoCIII, and ApoAII by members of the steroid hormone receptor superfamily HNF-4, ARP-1, EAR-2, and EAR-3.

Authors:  J A Ladias; M Hadzopoulou-Cladaras; D Kardassis; P Cardot; J Cheng; V Zannis; C Cladaras
Journal:  J Biol Chem       Date:  1992-08-05       Impact factor: 5.157

5.  The sequence of a murine cDNA encoding Ear-2, a nuclear orphan receptor.

Authors:  K M Barnhart; P L Mellon
Journal:  Gene       Date:  1994-05-16       Impact factor: 3.688

6.  PEBP2 alpha B/mouse AML1 consists of multiple isoforms that possess differential transactivation potentials.

Authors:  S C Bae; E Ogawa; M Maruyama; H Oka; M Satake; K Shigesada; N A Jenkins; D J Gilbert; N G Copeland; Y Ito
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

7.  Growth and differentiation signals mediated by different regions in the cytoplasmic domain of granulocyte colony-stimulating factor receptor.

Authors:  R Fukunaga; E Ishizaka-Ikeda; S Nagata
Journal:  Cell       Date:  1993-09-24       Impact factor: 41.582

8.  Growth inhibition and induction of differentiation of t(8;21) acute myeloid leukemia cells by the DNA-binding domain of PEBP2 and the AML1/MTG8(ETO)-specific antisense oligonucleotide.

Authors:  C Sakakura; Y Yamaguchi-Iwai; M Satake; S C Bae; A Takahashi; E Ogawa; A Hagiwara; T Takahashi; A Murakami; K Makino
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

9.  Isolation of PEBP2 alpha B cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1.

Authors:  S C Bae; Y Yamaguchi-Iwai; E Ogawa; M Maruyama; M Inuzuka; H Kagoshima; K Shigesada; M Satake; Y Ito
Journal:  Oncogene       Date:  1993-03       Impact factor: 9.867

10.  The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript.

Authors:  H Miyoshi; T Kozu; K Shimizu; K Enomoto; N Maseki; Y Kaneko; N Kamada; M Ohki
Journal:  EMBO J       Date:  1993-07       Impact factor: 11.598

View more
  17 in total

1.  Genomic heterogeneity in core-binding factor acute myeloid leukemia and its clinical implication.

Authors:  Nikolaus Jahn; Tobias Terzer; Eric Sträng; Anna Dolnik; Sibylle Cocciardi; Ekaterina Panina; Andrea Corbacioglu; Julia Herzig; Daniela Weber; Anika Schrade; Katharina Götze; Thomas Schröder; Michael Lübbert; Dominique Wellnitz; Elisabeth Koller; Richard F Schlenk; Verena I Gaidzik; Peter Paschka; Frank G Rücker; Michael Heuser; Felicitas Thol; Arnold Ganser; Axel Benner; Hartmut Döhner; Lars Bullinger; Konstanze Döhner
Journal:  Blood Adv       Date:  2020-12-22

2.  Filamin A-bound PEBP2beta/CBFbeta is retained in the cytoplasm and prevented from functioning as a partner of the Runx1 transcription factor.

Authors:  Naomi Yoshida; Takehiro Ogata; Kenji Tanabe; Songhua Li; Megumi Nakazato; Kazuyoshi Kohu; Toshiro Takafuta; Sandor Shapiro; Yasutaka Ohta; Masanobu Satake; Toshio Watanabe
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

3.  Dichotomy of AML1-ETO functions: growth arrest versus block of differentiation.

Authors:  S A Burel; N Harakawa; L Zhou; T Pabst; D G Tenen; D E Zhang
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

4.  ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain.

Authors:  J M Amann; J Nip; D K Strom; B Lutterbach; H Harada; N Lenny; J R Downing; S Meyers; S W Hiebert
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

Review 5.  A role for RUNX1 in hematopoiesis and myeloid leukemia.

Authors:  Motoshi Ichikawa; Akihide Yoshimi; Masahiro Nakagawa; Nahoko Nishimoto; Naoko Watanabe-Okochi; Mineo Kurokawa
Journal:  Int J Hematol       Date:  2013-04-24       Impact factor: 2.490

6.  The p21Waf1 pathway is involved in blocking leukemogenesis by the t(8;21) fusion protein AML1-ETO.

Authors:  Luke F Peterson; Ming Yan; Dong-Er Zhang
Journal:  Blood       Date:  2007-02-06       Impact factor: 22.113

7.  Stem cell expression of the AML1/ETO fusion protein induces a myeloproliferative disorder in mice.

Authors:  Timothy S Fenske; Gina Pengue; Vikram Mathews; Piia T Hanson; Sarah E Hamm; Noor Riaz; Timothy A Graubert
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-11       Impact factor: 11.205

8.  p53 signaling in response to increased DNA damage sensitizes AML1-ETO cells to stress-induced death.

Authors:  Ondrej Krejci; Mark Wunderlich; Hartmut Geiger; Fu-Sheng Chou; David Schleimer; Michael Jansen; Paul R Andreassen; James C Mulloy
Journal:  Blood       Date:  2007-11-01       Impact factor: 22.113

9.  Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors.

Authors:  D Levanon; R E Goldstein; Y Bernstein; H Tang; D Goldenberg; S Stifani; Z Paroush; Y Groner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

10.  Different roles of E proteins in t(8;21) leukemia: E2-2 compromises the function of AETFC and negatively regulates leukemogenesis.

Authors:  Na Liu; Junhong Song; Yangyang Xie; Xiao-Lin Wang; Bowen Rong; Na Man; Meng-Meng Zhang; Qunling Zhang; Fei-Fei Gao; Mei-Rong Du; Ying Zhang; Jian Shen; Chun-Hui Xu; Cheng-Long Hu; Ji-Chuan Wu; Ping Liu; Yuan-Liang Zhang; Yin-Yin Xie; Ping Liu; Jin-Yan Huang; Qiu-Hua Huang; Fei Lan; Shuhong Shen; Stephen D Nimer; Zhu Chen; Sai-Juan Chen; Robert G Roeder; Lan Wang; Xiao-Jian Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.